https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-05-13 / J Clin Biochem Nutr 2014 Jul;55(1):56-61
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-05-13 / J Clin Biochem Nutr 2014 Jul;55(1):56-612014-05-13 00:00:002019-02-15 09:17:12The inhibitory effect of heat treatment against epithelial-mesenchymal transition (EMT) in human pancreatic adenocarcinoma cell lines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-05-12 / Virol. J. 2014 May;11:84
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-05-12 / Virol. J. 2014 May;11:842014-05-12 00:00:002014-05-12 00:00:00Oncolytic therapy of a recombinant Newcastle disease virus D90 strain for lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-05-07 / J Ovarian Res 2014 May;7:48
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-05-07 / J Ovarian Res 2014 May;7:482014-05-07 00:00:002019-02-15 08:52:06The feasibility and clinical effects of dendritic cell-based immunotherapy targeting synthesized peptides for recurrent ovarian cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-05-02 / Expert Rev Clin Immunol 2014 Jun;10(6):705-11
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-05-02 / Expert Rev Clin Immunol 2014 Jun;10(6):705-112014-05-02 00:00:002021-11-15 13:30:54Wilms‘ tumor gene 1 immunotherapy in pelvic gynecological malignancies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-05-01 / Future Oncol 2014 May;10(6):911-5
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-05-01 / Future Oncol 2014 May;10(6):911-52014-05-01 00:00:002019-02-15 08:46:22Immunotherapy for high-grade glioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-05-01 / Cytotherapy 2014 Jul;16(7):934-45
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-05-01 / Cytotherapy 2014 Jul;16(7):934-452014-05-01 00:00:002014-05-01 00:00:00Adoptive cellular immunotherapy for the treatment of patients with breast cancer: a meta-analysis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-04-29 / Cancer Immunol. Immunother. 2014 Aug;63(8):797-806
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-04-29 / Cancer Immunol. Immunother. 2014 Aug;63(8):797-8062014-04-29 00:00:002019-02-15 08:52:30Prognostic factors related to add-on dendritic cell vaccines on patients with inoperable pancreatic cancer receiving chemotherapy: a multicenter analysis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-04-14 / World J. Gastroenterol. 2014 Apr;20(14):3738-50
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-04-14 / World J. Gastroenterol. 2014 Apr;20(14):3738-502014-04-14 00:00:002019-02-15 08:39:39Colorectal cancer and immunity: what we know and perspectives
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-04-10 / Korean J Thorac Cardiovasc Surg 2014 Apr;47(2):77-93
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-04-10 / Korean J Thorac Cardiovasc Surg 2014 Apr;47(2):77-932014-04-10 00:00:002019-02-15 08:35:16Current status of oncothermia therapy for lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-04-10 / Cell 2014 Apr;157(2):516-516.e1
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-04-10 / Cell 2014 Apr;157(2):516-516.e12014-04-10 00:00:002019-02-15 08:39:41SnapShot: cancer vaccines
